SEC Comment Letter 0000000000-24-010191 to Aditxt, Inc. (ADTX)
Aditxt, Inc.
Date: Sept. 9, 2024 · CIK: 0001726711 · Accession: 0000000000-24-010191
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281988
Letter
September 9, 2024 Amro Albanna Chief Executive Officer Aditxt, Inc. 2569 Wyandotte Street Suite 101 Mountain View, CA 94043 Re:Aditxt, Inc. Registration Statement on Form S-3 Filed September 6, 2024 File No. 333-281988 Dear Amro Albanna: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at 202-551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Richard A. Friedman, Esq.
Show Raw Text
September 9, 2024
Amro Albanna
Chief Executive Officer
Aditxt, Inc.
2569 Wyandotte Street
Suite 101
Mountain View, CA 94043
Re:Aditxt, Inc.
Registration Statement on Form S-3
Filed September 6, 2024
File No. 333-281988
Dear Amro Albanna:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at 202-551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Richard A. Friedman, Esq.